Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)
11:06pm, Friday, 31'st May 2024
Moderna, Inc. (NASDAQ:MRNA ) Bernstein's 40th Annual Strategic Decisions Conference May 31, 2024 10:00 PM ET Company Participants Stephane Bancel - CEO Conference Call Participants Courtney Breen - Be
Moderna wins second product approval with RSV vaccine
11:56am, Friday, 31'st May 2024
Moderna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has been approved for a d
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
11:53am, Friday, 31'st May 2024
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
11:09am, Friday, 31'st May 2024
The Food and Drug Administration approved Moderna's vaccine for respiratory syncytial virus. The decision is a win for Moderna, which desperately needs another revenue source amid plunging demand for
US FDA approves Moderna's RSV vaccine, its second marketed product
11:06am, Friday, 31'st May 2024
The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second produ
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
10:58am, Friday, 31'st May 2024
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announc
3 Sorry Biotech Stocks to Sell in May While You Still Can
07:00am, Friday, 31'st May 2024
Morgan Stanley recently released its bullish take on the biotech space, driven by anticipated interest rate cuts and a surge in mergers and acquisitions (M&A) activity. The analyst firm states biotech
Why Moderna Stock Is Sinking This Week
04:21pm, Thursday, 30'th May 2024
Investors appear to be taking profits after Moderna stock soared last week. The big moves center around concerns about the H5N1 avian flu, also known as bird flu.
New U.S. bird-flu case is first with respiratory symptoms, CDC says
02:52pm, Thursday, 30'th May 2024
A new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve acute respiratory symptoms, the Centers for Disease Control and Prevention said Thursday.
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
09:22am, Thursday, 30'th May 2024
Moderna stock jumped early Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.
Moderna's stock climbs on report that bird-flu vaccine funding is near
09:10am, Thursday, 30'th May 2024
Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.
Option Trade On Volatile Moderna Could Return 28% By Mid-July
08:30am, Thursday, 30'th May 2024
This iron condor trade on Moderna has the potential to return 28% if the stock price stays between 118.90 and 181.10.
3 Nasdaq Stocks to Dump as They Near Peak Performance
06:00am, Thursday, 30'th May 2024
The Nasdaq hit a new record high again on Tuesday. It has investors wondering which Nasdaq stocks to sell to lock in profits before the upside runs its course.
U.S. Government Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
02:11am, Thursday, 30'th May 2024
The U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu vaccine made by Moderna, the Financial Times reported Thursday, at a time when the country is battl
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
12:51am, Thursday, 30'th May 2024
The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA pandemic bird flu vaccine, the Financial Times reported on Thursday, as an H5N1 outbreak spreads through egg fa
